EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives: An evidence‐based review with good practice points
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Despite being one of the most devastating diseases known, there is little evidence for diagnosing and managing patients with amyotrophic lateral sclerosis (ALS). Although specific therapy is lacking, correct early diagnosis and introduction of symptomatic and specific therapy can have a profound influence on the care and quality of life of the patient and may increase survival time. This document addresses the optimal clinical approach to ALS. The final literature search was performed in the spring of 2005. Consensus recommendations are given graded according to the EFNS guidance regulations. Where there was lack of evidence but consensus was clear we have stated our opinion as good practice points. People affected with possible ALS should be examined as soon as possible by an experienced neurologist. Early diagnosis should be pursued and a number of investigations should be performed with high priority. The patient should be informed of the diagnosis by a consultant with a good knowledge of the patient and the disease. Following diagnosis, the patient and relatives should receive regular support from a multidisciplinary care team. Medication with riluzole should be initiated as early as possible. PEG is associated with improved nutrition and should be inserted early. The operation is hazardous in patients with vital capacity <50%. Non‐invasive positive pressure ventilation improves survival and quality of life but is underused. Maintaining the patients ability to communicate is essential. During the entire course of the disease, every effort should be made to maintain patient autonomy. Advance directives for palliative end of life care are important and should be fully discussed early with the patient and relatives respecting the patients social and cultural background.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433 · cited 2×
“Where there was lack of evidence but consensus was clear we have stated our opinion as good practice points.”
BackgroundMethodA Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
Bensimon, G., Lacomblez, L., & Meininger, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300901 · Cited by 2,233
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V, Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,301
Self-citationRiluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R. G., Mitchell, J. D., & Moore, D. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447.pub3 · Cited by 1,058
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R., Mitchell, J., Lyon, M., & Moore, D. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447 · Cited by 909
Haverkamp, L. J., Appel, V., & Appel, S. H. (1995) · Brain · doi:10.1093/brain/118.3.707 · Cited by 696
A systematic review of the use of opioids in the management of dyspnoea
Jennings, A.-L. (2002) · Thorax · doi:10.1136/thorax.57.11.939 · Cited by 644
Miller, R. G., Rosenberg, J. A., Gelinas, D. F., Mitsumoto, H., Newman, D., Sufit, R., Borasio, G. D., Bradley, W. G., Bromberg, M. B., Brooks, B. R., et al. (1999) · Neurology · doi:10.1212/wnl.52.7.1311 · Cited by 574
Self-citationVandeKieft, G. K. (2001) · PubMed · Cited by 567
Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis
Cudkowicz, M. E., McKenna‐Yasek, D., Sapp, P. E., Chin, W., Geller, B., Hayden, D. L., Schoenfeld, D. A., Hosler, B. A., Horvitz, H. R., & Brown, R. H. (1997) · Annals of Neurology · doi:10.1002/ana.410410212 · Cited by 533
Traynor, B. J. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1258 · Cited by 493
Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine: A randomized trial
Brooks, B. R., Thisted, R. A., Appel, S. H., Bradley, W. G., Olney, R. K., Berg, J. E., Pope, L. E., & Smith, R. A. (2004) · Neurology · doi:10.1212/01.wnl.0000142042.50528.2f · Cited by 434
Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis
Lyall, R. A. (2001) · Brain · doi:10.1093/brain/124.10.2000 · Cited by 384
Brainin, M., Barnes, M., Baron, J. ‐., Gilhus, N. E., Hughes, R., Selmaj, K., & Waldemar, G. (2004) · European Journal of Neurology · doi:10.1111/j.1468-1331.2004.00867.x · Cited by 375
The use of opioids and sedatives at the end of life
Sykes, N., & Thorns, A. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01079-9 · Cited by 354
Andersen, P. (1997) · Brain · doi:10.1093/brain/120.10.1723 · Cited by 306
Self-citationNoninvasive ventilation in ALS: Indications and effect on quality of life
Bourke, S. C., Bullock, R. E., Williams, T. L., Shaw, P. J., & Gibson, G. J. (2003) · Neurology · doi:10.1212/01.wnl.0000076182.13137.38 · Cited by 301
The value of muscle exercise in patients with amyotrophic lateral sclerosis
Drory, V. E., Goltsman, E., Goldman Reznik, J., Mosek, A., & Korczyn, A. D. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00610-4 · Cited by 283
Andersen, P. M., Sims, K. B., Xin, W. W., Kiely, R., O'Neill, G., Ravits, J., Pioro, E., Harati, Y., Brower, R. D., Levine, J. S., et al. (2003) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310011700 · Cited by 282
Self-citationLeone, M. A., Brainin, M., Boon, P., Pugliatti, M., Keindl, M., & Bassetti, C. L. (2013) · European Journal of Neurology · doi:10.1111/ene.12043 · Cited by 280
Sialorrhea: a management challenge.
Hockstein, N. G., Samadi, D. S., Gendron, K. B., & Handler, S. D. (2004) · PubMed · Cited by 280
Frontal lobe dysfunction in amyotrophic lateral sclerosis: A PET study
Abrahams, S., Goldstein, L. H., Kew, J. J. M., Brooks, D. J., Lloyd, C. M., Frith, C. D., & Leigh, P. N. (1996) · Brain · doi:10.1093/brain/119.6.2105 · Cited by 276
Self-citationAndersen, P. M., Forsgren, L., Binzer, M., Nilsson, P., Ala-Hurula, V., Keranen, M. L., Bergmark, L., Saarinen, A., Haltia, T., Tarvainen, I., et al. (1996) · Brain · doi:10.1093/brain/119.4.1153 · Cited by 272
Self-citationAmyotrophic Lateral Sclerosis Mimic Syndromes: A Population-Based Study
Traynor, B. J., Codd, M. B., Corr, B., Forde, C., Frost, E., & Hardiman, O. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.109 · Cited by 242
Self-citationTreatment of Pathologic Laughing and Weeping with Amitriptyline
Schiffer, R. B., Herndon, R. M., & Rudick, R. A. (1985) · New England Journal of Medicine · doi:10.1056/nejm198506063122303 · Cited by 233
Citalopram for post-stroke pathological crying
Andersen, G., Vestergaard, K., & Riis, J. O. (1993) · The Lancet · doi:10.1016/0140-6736(93)92696-q · Cited by 232
The management of motor neurone disease
Leigh, P. N. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.suppl_4.iv32 · Cited by 226
Self-citationInce (1998) · doi:10.1046/j.1365-2990.1998.00108.x · Cited by 224
The effects of motor neurone disease on language: Further evidence
Bak, T. H., & Hodges, J. R. (2004) · Brain and Language · doi:10.1016/s0093-934x(03)00357-2 · Cited by 218
Sancho, J., Servera, E., Díaz, J., & Marín, J. (2004) · Chest · doi:10.1378/chest.125.4.1400 · Cited by 204
Giess, R. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.1.121 · Cited by 199
Nutritional assessment and survival in ALS patients
Claude Desport, P. M. P. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515386 · Cited by 198
Treatment of Sialorrhea With Glycopyrrolate: A Double-blind, Dose-Ranging Study
Mier, R. J., Bachrach, S. J., Lakin, R. C., Barker, T., Childs, J., & Moran, M. (2000) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.154.12.1214 · Cited by 197
Palliative care in amyotrophic lateral sclerosis
Borasio, G. D., Voltz, R., & Miller, R. G. (2001) · Neurologic Clinics · doi:10.1016/s0733-8619(05)70049-9 · Cited by 193
Self-citationCazzolli, P. A., & Oppenheimer, E. A. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00099-8 · Cited by 190
An outcome study of riluzole in amyotrophic lateral sclerosis
Traynor, B. J., Alexander, M. D., Corr, B., Frost, E., & Hardiman, O. M. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1026-z · Cited by 174
Self-citationAmyotrophic Lateral Sclerosis: Clinical Features and Prognosis
Rosen, A. D. (1978) · Archives of Neurology · doi:10.1001/archneur.1978.00500340014003 · Cited by 173
Dogu, O., Apaydin, D., Sevim, S., Talas, D. U., & Aral, M. (2004) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2003.10.012 · Cited by 164
Sublingual Atropine for sialorrhea secondary to parkinsonism: A pilot study
Hyson, H. C., Johnson, A. M., & Jog, M. S. (2002) · Movement Disorders · doi:10.1002/mds.10276 · Cited by 163
Chio, A. (2004) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.020347 · Cited by 148
Mutations in all five exons of SOD‐1 may cause ALS
Shaw, C. E., Enayat, Z. E., Chioza, B. A., Al‐Chalabi, A., Radunovic, A., Powell, J. F., & Leigh, P. N. (1998) · Annals of Neurology · doi:10.1002/ana.410430319 · Cited by 147
Self-citationTelling the diagnosis of cancer.
Lind, S. E., DelVecchio Good, M. J., Seidel, S., Csordas, T., & Good, B. J. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.5.583 · Cited by 145
Chiò, A. (1999) · Journal of Neurology · doi:10.1007/bf03161081 · Cited by 143
EFFICACY OF BENZTROPINE THERAPY FOR DROOLING
Camp, J. A., Winsberg, B. G., Green-Parsons, A., & Abrams, J. P. (1989) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1989.tb04000.x · Cited by 140
Aggarwal, A. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.73.2.199 · Cited by 139
Pathologic laughter and crying in ALS: a search for their origin
Gallagher, J. P. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb03851.x · Cited by 138
Mathus-Vliegen, L., Louwerse, L. S., Merkus, M. P., Tytgat, G. N. J., & de Jong, J. M. B. V. (1994) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(94)70211-x · Cited by 137
Prognosis of amyotrophic lateral sclerosis and the effect of referral selection
Lee, J. R.-J., Annegers, J. F., & Appel, S. H. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00154-t · Cited by 133
Davenport, R. J., Swingler, R. J., Chancellor, A. M., & Warlow, C. P. (1996) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.2.147 · Cited by 132
Letters to patients: improving communication in cancer care
Damian, D. L., & Tattersall, M. H. N. (1991) · The Lancet · doi:10.1016/0140-6736(91)91782-p · Cited by 131
Amyotrophic Lateral Sclerosis: Enteral Nutrition Provision—Endoscopic or Radiologic Gastrostomy?
Thornton, F. J., Fotheringham, T., Alexander, M., Hardiman, O., McGrath, F. P., & Lee, M. J. (2002) · Radiology · doi:10.1148/radiol.2243010909 · Cited by 131
Self-citationEpidemiology of motor neuron disease in northern Sweden
Forsgren, L., Almay, B. G. L., & Wall, S. (1983) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1983.tb04810.x · Cited by 130
Jackson, M., Al‐Chalabi, A., Enayat, Z. E., Chioza, B., Leigh, P. N., & Morrison, K. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420518 · Cited by 130
Self-citationComparison of sporadic and familial disease amongst 580 cases of motor neuron disease.
Li, T. M., Alberman, E., & Swash, M. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.778 · Cited by 128
The Use of Hydrotherapy for the Management of Spasticity
Kesiktaş, F. N., Paker, N., Erdogan, N., Gulsen, G., Biçki, D., & Yılmaz, H. G. (2004) · Neurorehabilitation and neural repair · doi:10.1177/1545968304270002 · Cited by 125
A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea
Bruera, E. D., Sweeney, C., Willey, J. S., Palmer, J. L., Strasser, F., Morice, R. C., & Pisters, K. M. W. (2003) · Palliative Medicine · doi:10.1191/0269216303pm826oa · Cited by 124
Nutritional management in MND/ALS patients: an evidence based review
Heffernan, C., Jenkinson, C., Holmes, T., Feder, G., Kupfer, R., Leigh, P. N., McGowan, S., Rio, A., & Sidhu, P. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820410020349 · Cited by 121
Self-citationBorasio, G., Shaw, P., Hardiman, O., Ludolph, A., Luis, M. S., & Silani, V (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608201753275517 · Cited by 120
Self-citationSOD1 mutations in amyotrophic lateral sclerosis: Results from a multicenter Italian study
Battistini, S., Giannini, F., Greco, G., Bibbò, G., Ferrera, L., Marini, V., Causarano, R., Casula, M., Lando, G., Patrosso, M. C., et al. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0742-y · Cited by 120
Hanayama, K., Ishikawa, Y., & Bach, J. R. (1997) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/00002060-199707000-00017 · Cited by 113
Amyotrophic lateral sclerosis in Middle-Finland: an epidemiological study
Murros, K., & Fogelholm, R. (1983) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1983.tb04543.x · Cited by 104
A survey of clinicians' practice in the symptomatic treatment of ALS
A Forshew, D., & B Bromberg, M. (2003) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820310017344 · Cited by 101
Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis
Turner, M., Bakker, M., Sham, P., Shaw, C., Leigh, P., & Al-Chalabi, A. (2002) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608202317576499 · Cited by 97
Self-citationThe control of oral secretions in bulbar ALS/MND
Newall, A. R., Orser, R., & Hunt, M. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00104-9 · Cited by 96
Breaking the news in amyotrophic lateral sclerosis
Borasio, G. D., Sloan, R., & Pongratz, D. E. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00211-1 · Cited by 96
Self-citationBreaking the news: A survey of ALS patients and their caregivers
Mccluskey, L., Casarett, D., & Siderowf, A. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820410020772 · Cited by 93
Treatment of Nocturnal Leg Cramps: A Crossover Trial of Quinine vs Vitamin E
Connolly, P. S., Shirley, E. A., Wasson, J. H., & Nierenberg, D. W. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.9.1877 · Cited by 93
Toward earlier diagnosis of amyotrophic lateral sclerosis: Revised criteria
Ross, M. A., Miller, R. G., Berchert, L., Parry, G., Barohn, R. J., Armon, C., Bryan, W. W., Petajan, J., Stromatt, S., Goodpasture, J., et al. (1998) · Neurology · doi:10.1212/wnl.50.3.768 · Cited by 90
AMYOTROPHIC LATERAL SCLEROSIS IN FINLAND: II: Clinical Characteristics
Jokelainen, M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1977.tb01425.x · Cited by 89
Jones, C. T., Swingler, R. J., Simpson, S. A., & Brock, D. J. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.4.290 · Cited by 88
Management of motor neurone disease
Howard, R. S., & Orrell, R. W. (2002) · Postgraduate Medical Journal · doi:10.1136/pmj.78.926.736 · Cited by 88
Epidemiology of Motor-Neuron Diseases
Bobowick, A. R., & Brody, J. A. (1973) · New England Journal of Medicine · doi:10.1056/nejm197305172882005 · Cited by 87
Orrell, R. W., Habgood, J., Gardiner, I. M., King, A. W., Bowe, F., Hallewell, R. A., Marklund, S. L., Greenwood, J., Lane, R. J. M., & deBelleroche, J. (1997) · Neurology · doi:10.1212/wnl.48.3.746 · Cited by 86
Andersen, P. M., Grönberg, H., Franzén, L., & Funegård, U. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00631-1 · Cited by 80
Self-citationMisdiagnosis in Patients With Amyotrophic Lateral Sclerosis
Belsh, J. M. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.11.2301 · Cited by 79
Tan, E., Lo, Y. L., Seah, A., & Auchus, A. P. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00565-2 · Cited by 79
Winterholler, M., Erbguth, F. J., Wolf, S., & Kat, S. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.3.417 · Cited by 78
Diener, H., Dethlefsen, U., Dethlefsen‐Gruber, S., & Verbeek, P. (2002) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2002.tb11248.x · Cited by 70
Pharmacologic Treatment of Emotional Lability
Iannaccone, S., & Ferini‐Strambi, L. (1996) · Clinical Neuropharmacology · doi:10.1097/00002826-199619060-00008 · Cited by 68
Identification of Six Novel SOD1 Gene Mutations in Familial Amyotrophic Lateral Sclerosis
Boukaftane, Y., Khoris, J., Moulard, B., Salachas, F., Meininger, V., Malafosse, A., Camu, W., & Rouleau, G. A. (1998) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100034004 · Cited by 67
Wilbourn, A. J. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00194-4 · Cited by 65
Motor Neuron Disease in Hong Kong Chinese: Epidemiology and Clinical Picture
Fong, K., Yu, Y. L., Chan, Y., Kay, R., Chan, J. W. M., Yang, Z., Kwan, M. C. L., Leung, K., Li, P. C. K., Lam, T., et al. (1996) · Neuroepidemiology · doi:10.1159/000109913 · Cited by 60
Epidemiologic study of amyotrophic lateral sclerosis in Sardinia, Italy
Giagheddu, M., Puggioni, G., Masala, C., Biancu, F., Pirari, G., Piras, M. R., & Rachele, M. G. (1983) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1983.tb04849.x · Cited by 58
Motor Neuron Disease and Heavy Manual Labor: An Epidemiologic Survey of Värmland County, Sweden
Gunnarsson, L.-G., & Palm, R. (1984) · Neuroepidemiology · doi:10.1159/000110854 · Cited by 57
Reduction of salivary flow with transdermal scopolamine: A four‐year experience
Talmi, Y. P., Finkelstein, Y., & Zohar, Y. (1990) · Otolaryngology · doi:10.1177/019459989010300415 · Cited by 55
Use of Radiotherapy for Control of Sialorrhea in Patients with Amyotrophic Lateral Sclerosis
Harriman, M., Morrison, M. D., Hay, J., Revonta, M., Eisen, A., & Lentle, B. C. (2001) · The Journal of Otolaryngology · doi:10.2310/7070.2001.19779 · Cited by 55
Shaw, A. S., Ampong, M. A., Rio, A., McClure, J. T., Leigh, P. N., & Sidhu, P. S. (2004) · Radiology · doi:10.1148/radiol.2332031487 · Cited by 53
Self-citationAmyotrophic lateral sclerosis care in Italy: a nationwide study in neurological centers
Chiò, A., & Silani, V. (2001) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(01)00622-0 · Cited by 49
Self-citationResults of radiotherapy for drooling in amyotrophic lateral sclerosis
Stalpers, L. J. A., & Moser, E. C. (2002) · Neurology · doi:10.1212/wnl.58.8.1308 · Cited by 48
Communication strategies of people with ALS and their partners
Murphy, J. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820410020411 · Cited by 47
Language impairment in motor neurone disease
Cobble, M. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00198-1 · Cited by 46
Non‐invasive ventilation in ALS: current practice and future role
Bourke, S. C., & Gibson, G. J. (2004) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820410020330 · Cited by 44
Otolaryngologic manifestations of amyotrophic lateral sclerosis.
Janzen, V. D., Rae, R. E., & Hudson, A. J. (1988) · PubMed · Cited by 41
Nasogastric feeding in the management of severe dysphagia in motor neurone disease
Scott, A., & Austin, H. E. (1994) · Palliative Medicine · doi:10.1177/026921639400800108 · Cited by 41
Good practice in the management of adults with malignant cerebral glioma: clinical guidelines
HOPKINS, E. D. &. A. (1997) · British Journal of Neurosurgery · doi:10.1080/02688699746104 · Cited by 41
García‐Redondo, A., de Bustos, F., Seva, B. J. Y., del Hoyo, P., Jiménez, S., Campos, Y., Martín, M. A., Rubio‐Terres, C., Cañadillas, F., Arenas, J., et al. (2002) · Muscle & Nerve · doi:10.1002/mus.10193 · Cited by 40
DIFFERENTIAL DIAGNOSIS OF MOTONEURONE DISEASE FROM OTHER NEUROLOGICAL CONDITIONS
MINGLI, T. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90243-6 · Cited by 39
The Surgical Management of Drooling
Burton, M. J. (1991) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1991.tb14835.x · Cited by 39
Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population.
Thijs, V., Peeters, E. A. J., Theys, P., Matthijs, G., & Robberecht, W. (2000) · PubMed · Cited by 39
Trial of Baclofen in Amyotrophic Lateral Sclerosis
Norris, F. H., Kim, U., Sachais, B. A., & Carey, M. (1979) · Archives of Neurology · doi:10.1001/archneur.1979.00500470085019 · Cited by 38
Incidence and Prevalence of Motor Neuron Disease in Two Danish Counties
Højer‐Pedersen, E., Christensen, P., & Jensen, N. B. (1989) · Neuroepidemiology · doi:10.1159/000110177 · Cited by 37
Examining the evidence about treatment in ALS/MND
Miller, R. G. (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608201300079355 · Cited by 36
Use of intrathecal baclofen for treatment of spasticity in amyotrophic lateral sclerosis
Marquardt, G., & Seifert, V. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.275 · Cited by 35
Amyotrophic lateral sclerosis among the migrant population to Piemonte, northwestern Italy
Chi�, A., Cucatto, A., Calvo, A., Terreni, A., Magnani, C., & Schiffer, D. (1999) · Journal of Neurology · doi:10.1007/s004150050330 · Cited by 35
Familial ALS in Germany: origin of the R115G SOD1 mutation by a founder effect
Niemann, S. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.028324 · Cited by 35
Recurrent trismus and stridor in an ALS patient: Successful treatment with botulinum toxin
Winterholler, M., Heckmann, J. G., Hecht, M. J., & Erbguth, F. J. (2002) · Neurology · doi:10.1212/wnl.58.3.502 · Cited by 34
Members of the task force on molecular diagnosis of neurologic disorders: T. Gasser, G. M. D. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00228.x · Cited by 23
Genetics of ALS in Italian families
Gellera, C. (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820152415735 · Cited by 22
Motor neuropathies mimicking amyotrophic lateral sclerosis/motor neuron disease
Evangelista, T., de Carvalho, M. A., Conceição, I. M., Pinto, A. C., & Luís, M. L. S. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00120-7 · Cited by 21
known, I. T. G. C. A. N. D. I., Usually, D. M. D. C. B. P. B. M. A. O. D. F. T. A. I. I. R., type, E. W. A. K. T. H. M. I. T. P. D. W. B. A. F. D. W. H. B. E. F. P. B. L. B. P. D. O. I., electrophoresis, T. M. W. T. B. D. E. D. B. G., gene, D. B. R. E. O. B. D. S. I. A. G. I. V. L. (. W. M. T. 3. E. A. N. U. A. M. A. S. T. T. E., cases, D. M. A. C. B. V. C. A. T.-C. I. T., Gené, R., CADASIL, W. M. M. B. C. E. G. I., & gene)., W. 7. O. M. A. F. I. E. 3. A. 4. O. T. N. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00226.x · Cited by 21
Getting the diagnosis right: Beyond El Escorial
Meininger, V. (1999) · Journal of Neurology · doi:10.1007/bf03161083 · Cited by 20
ACCELERATING THE DIAGNOSIS OF AMYOTROPHIC LATERAL SCLEROSIS
Bromberg, M. B. (1999) · The Neurologist · doi:10.1097/00127893-199903000-00002 · Cited by 19
Talmi, Y. P., Finkelstein, Y., Zohar, Y., Hillel, A., & Miller, R. P. (1989) · Head & Neck · doi:10.1002/hed.2880110617 · Cited by 15
Palliative medicine at the crossroads.
Gm, A., & Dj, O. (1997) · PubMed · Cited by 14
Treatment of Nocturnal Leg Cramps
Brunetti, L. L. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.9.1037 · Cited by 12
Cited by
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603
Self-citationThe EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis:, Andersen, P. M., Abrahams, S., Borasio, G. D., de Carvalho, M., Chio, A., Van Damme, P., Hardiman, O., Kollewe, K., Morrison, K. E., et al. (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03501.x · Cited by 1,117
Self-citationMiller, R. G., Jackson, C. E., Kasarskis, E. J., England, J. D., Forshew, D., Johnston, W., Kalra, S., Katz, J. S., Mitsumoto, H., Rosenfeld, J., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc0141 · Cited by 807
Clinical genetics of amyotrophic lateral sclerosis: what do we really know?
Andersen, P. M., & Al-Chalabi, A. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.150 · Cited by 687
Self-citationMiller, R. G., Jackson, C. E., Kasarskis, E. J., England, J. D., Forshew, D., Johnston, W., Kalra, S., Katz, J. S., Mitsumoto, H., Rosenfeld, J., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc01a4 · Cited by 674
Metadata
- Authors
- Andersen, P. M., Borasio, G. D., Dengler, R., Hardiman, O., Kollewe, K., Leigh, P. N., Pradat, P. ‐., Silani, V., & Tomik, B.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2005-11-30
- Volume
- 12
- Issue
- 12
- Pages
- 921-938
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W1554056672
- Cited by
- 289
- References
- 115
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.